RxDoctor Payments DataLook up a doctor →

ELZONRIS: payments to doctors

Payments that named ELZONRIS as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$1.8M
Providers
2,560
Transactions
4,288
Average per transaction
$428

The per-transaction average — $428 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,560 providers the average total is $717, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Stemline Therapeutics Inc.$1,834,24499.9%
Nippon Shinyaku Co.,ltd$2,0000.1%
← All drugs & devices